305
Participants
Start Date
April 30, 2007
Primary Completion Date
May 31, 2009
Study Completion Date
May 31, 2009
Pioglitazone and Metformin
Pioglitazone 15 mg/metformin 850 mg combination tablets, orally, twice daily and glimepiride placebo-matching tablets, orally, once daily and metformin placebo-matching tablets, orally, twice daily for up to 24 weeks.
Glimepiride and Metformin
Pioglitazone/metformin placebo-matching combination tablets, orally, twice daily and glimepiride 2 mg, tablets, orally, once daily and metformin 850 mg, tablets, orally, twice daily for up to 24 weeks.
Bretten
Deggingen
Dettenheim
Künzelsau
Rottweil
Spaichingen
Stockach
Wangen
Augsburg
Feldafing
Furth im Wald
Immenstadt im Allgäu
Lichtenfels
München
Schweinfurt
Waldkraiburg
Wallerfing
Weilersbach
Würzburg
Ketzin
Rüdersdorf
Bermerhaven
Hamburg
Bensheim
Ehrenberg
Gersfeld
Kassel
Kelkheim
Offenbach
Celle
Einbeck
Hanover
Hildesheim
Schwerin
Bad Berleburg
Bad Laasphe
Bad Oeynhausen
Bocholt
Cologne
Dinslaken
Dorsten
Duisburg
Essen
Frechen
Isselburg
Kamen
Marl
Menden
Münster
Siegen
Diez
Mainz
Neuwied
Rodenbach
Simmern
Borna
Dresden
Meissen
Mittweida
Magdeburg
Reinfeld
Berlin
Altenburg
Blankenhain
Lead Sponsor
Takeda
INDUSTRY